William Compton
Chief Tech/Sci/R&D Officer at SEAGEN INC.
William Compton active positions
Companies | Position | Start | End |
---|---|---|---|
SEAGEN INC. | Chief Tech/Sci/R&D Officer | - | - |
Tech Impact
Tech Impact Information Technology ServicesTechnology Services Tech Impact is a non-profit organization, which engages in the provision of technological services. It help desk?managed IT services, office 365 for nonprofits, telecommunication, file management, data management, and digital and social media marketing. The company is headquartered in Philadelphia, PA. | Director/Board Member | - | - |
Career history of William Compton
Former positions of William Compton
Companies | Position | Start | End |
---|---|---|---|
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Chief Tech/Sci/R&D Officer | 31/01/2013 | 28/02/2023 |
CONVATEC GROUP PLC | Chief Tech/Sci/R&D Officer | 30/04/2008 | 30/09/2012 |
Training of William Compton
East Carolina University | Graduate Degree |
The College of William & Mary | Masters Business Admin |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
CONVATEC GROUP PLC | Health Technology |
Private companies | 2 |
---|---|
Tech Impact
Tech Impact Information Technology ServicesTechnology Services Tech Impact is a non-profit organization, which engages in the provision of technological services. It help desk?managed IT services, office 365 for nonprofits, telecommunication, file management, data management, and digital and social media marketing. The company is headquartered in Philadelphia, PA. | Technology Services |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- William Compton
- Experience